Results 321 to 330 of about 821,330 (390)

Evaluation of enzymatic pretreatment strategies to enhance anaerobic digestion of tomato waste

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Tomato residues are a form of solid waste that can be converted into methane through anaerobic digestion (AD). However, methane production is often limited due to incomplete hydrolysis caused by the high lignocellulosic content of tomato waste.
María Eugenia Martínez   +4 more
wiley   +1 more source

Sustainable biofuel production from fish processing waste: lipase‐catalyzed hydroesterification of tilapia residual oil

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Fishing waste and byproducts, whether naturally occurring or from industrial processing, are important sources of high‐value compounds. Fertilizers, biomaterials, cosmetics, biolubricants, and biodiesel are some of the substances that can be obtained from these residues. The objective of this study was to conduct a theoretical and experimental
Patrick da Silva Sousa   +7 more
wiley   +1 more source

Performance, emissions, and lubricant oil analysis of a marine diesel engine powered by raw Schizochytrium sp. and its blends

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Microalgae oil (MAO), a third‐generation biofuel, can support global transportation fuel demand as a fossil fuel substitute. Schizochytrium sp. MAO is particularly promising for direct use in compression ignition (CI) engines, especially in the marine sector, due to its adaptability and high oil yield.
Victor Debnath   +3 more
wiley   +1 more source

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman   +13 more
wiley   +1 more source

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy